Backstrom Jay T. - 29 Dec 2022 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jan 2023, 16:05:23 UTC
Prior SEC filing
22 Sep 2022
Next SEC filing
15 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

Backstrom Jay T. filed Form 4 for Disc Medicine, Inc. (IRON) on 03 Jan 2023.

Key facts

  • This page summarizes Backstrom Jay T.'s Form 4 filing for Disc Medicine, Inc. (IRON).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jan 2023, 16:05.

Change

  • Previous filing in this sequence was filed on 22 Sep 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+7,000
Change %
Price
$0.000000
Shares after
7,000
Date
29 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,000
Exercise price
$13.50
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2023 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .